---
title: "ApicHope's subsidiary has obtained the registration certificate for injectable isavuconazole"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255444556.md"
description: "ApicHope's wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Co., Ltd., recently obtained the registration certificate for injectable isavuconazole approved by the National Medical Products Administration. This drug is primarily used to treat invasive aspergillosis and invasive mucormycosis in adult patients. This registration certificate will enable the company to qualify for the sale of this drug in the domestic market, further enriching its product line and enhancing its competitiveness in the anti-infection field"
datetime: "2025-09-01T10:04:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255444556.md)
  - [en](https://longbridge.com/en/news/255444556.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255444556.md)
generator: "portal-rs"
---

# ApicHope's subsidiary has obtained the registration certificate for injectable isavuconazole

According to the Zhitong Finance APP, ApicHope (300723.SZ) announced that its wholly-owned subsidiary, Guangzhou ApicHope Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" for injectable isavuconazole approved by the National Medical Products Administration.

According to the approved instructions, the indications for injectable isavuconazole are: primarily used for the treatment of the following infections in adult patients: invasive aspergillosis; invasive mucormycosis. The acquisition of the injectable isavuconazole registration certificate marks that the company is qualified to sell this specification of drug in the domestic market, which will further enrich the company's product pipeline and product categories, enhancing the company's competitiveness in the anti-infection field

### Related Stocks

- [300723.CN](https://longbridge.com/en/quote/300723.CN.md)

## Related News & Research

- [Lighthouse Properties director associate buys shares worth ZAR 489,546.56](https://longbridge.com/en/news/296875782.md)
- [SP Group corrects disclosure, names Schur Finance as buyer of 31,500 shares at DKK 485](https://longbridge.com/en/news/296803384.md)
- [Foreign worker numbers to stay controlled despite business pressure](https://longbridge.com/en/news/296762549.md)
- [Ehrmann Family Raises Artmarket.com Stake as AI Strategy and Intellectual Legacy Take Center Stage](https://longbridge.com/en/news/296707881.md)
- [Laboratorios Richmond seeks partial debt delisting after repurchasing ARS 9.45 billion and USD 1.74 million notes](https://longbridge.com/en/news/296800183.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**